# A Clinical Trial to Examine the Efficacy and Safety of an Investigational Product With and Without Use of Semaglutide on Glycemic Response in Adults With Prediabetes or Type 2 Diabetes

> **NCT07195994** · NA · RECRUITING · sponsor: **QuickSilver Scientific** · enrollment: 90 (estimated)

## Conditions studied

- Prediabetes / Type 2 Diabetes

## Interventions

- **DIETARY_SUPPLEMENT:** AMPK Charge+®
- **DIETARY_SUPPLEMENT:** AMPK Charge+® with semaglutide

## Key facts

- **NCT ID:** NCT07195994
- **Lead sponsor:** QuickSilver Scientific
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-05
- **Primary completion:** 2026-09
- **Final completion:** 2026-09
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2026-03-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07195994

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07195994, "A Clinical Trial to Examine the Efficacy and Safety of an Investigational Product With and Without Use of Semaglutide on Glycemic Response in Adults With Prediabetes or Type 2 Diabetes". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT07195994. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*